Dexcel Pharma joins second funding round for BrainQ’s artificial intelligence (AI)-based technology.

Novartis Venture Fund returned as GentiBio raised money that will support the progress of its type 1 diabetes drug candidate toward clinical trials.

Blue Venture Fund led a round that included corporate venturing units GV and Optum Ventures, taking the medical imaging system developer's total funding to almost $60m.

Ventricular assistance system developer CH Biomedical closed a Baheal-backed series D round while peer-to-peer lending platform Alami secured $17.5m in a round led by EV Growth.

Early backers including Micromax Informatics are receiving 15-times returns on their investment in the health management app developer.

SoftBank Ventures Asia led ERP software provider Mabang's $46.3m series B round while Mainport Innovation Fund exited electrification technology developer ViriCiti.

Sino Biopharmaceutical was among the participants in a round valuing the drug development technology provider at over $2bn.

Nanox is paying up to $230m for corporate-backed medical technology developers Zebra Medical Vision and USARad, while electronics marketplace JustFit raised over $46m.

Country Garden Venture Capital led a $66.3m series B2 round for the bioplastic and pathogen detector developer that included Septwolves Venture Capital.

Leyaoyao raised a nine-digit yuan amount from investors including 37 Interactive Entertainment while Lockheed Martin and Booz Allen Hamilton contributed to AI developer Latent AI's series A round.